Key result
Type 2 diabetes was associated with platelet hyporesponsiveness to NO donors, with SNP inhibiting aggregation by 15.4% in diabetics versus 73.1% in healthy controls (p<0.05).
Why the study?
Does type 2 diabetes attenuate platelet responsiveness to nitric oxide donors compared to healthy controls?
Case-Control (n=27)
Does type 2 diabetes attenuate platelet responsiveness to nitric oxide donors compared to healthy controls?
Type 2 diabetes is associated with platelet hyporesponsiveness to nitric oxide donors and increased oxidative stress, which may contribute to increased atherothrombotic risk.
May heighten atherothrombotic risk in type 2 diabetes; hypothesis-generating and requires prospective confirmation.
Vascular responsiveness to exogenous nitrates in type 2 diabetes (T2DM) is attenuated in brachial and coronary vessels. We determined platelet responsiveness to nitric oxide (NO) in T2DM and control subjects. We examined whether the postprandial (PP) state affected platelet sensitivity to NO donors in T2DM patients and the extent of correlation between this and measures of oxidative stress, compared to changes in endothelial function. Twelve T2DM subjects were studied fasting and four hours after a test meal and compared with 15 healthy controls. We assessed the inhibitory effects of NO donors on adenosine 5'-diphosphate (ADP)-induced platelet aggregation. Oxidative stress was assessed by lipid-derived free radicals, ex vivo by electron paramagnetic resonance spectroscopy and markers of lipid peroxidation. Endothelial function was assessed by flow-mediated vasodilatation (FMD) of the brachial artery. Results are expressed as (mean +/- SEM). Fasting platelet aggregation was increased in diabetics versus controls (14.86 +/- 1.1 Ohms vs. 10.76 +/- 1.1 Ohms, p < 0.05). Sodium nitroprusside (SNP) and glyceryl trinitrate (GTN) inhibited ADP-induced aggregation by 73.1 +/- 5.9% and 50.3 +/- 7.7% in healthy controls compared to 15.4 +/- 7% and 19.5 +/- 8.2% in T2DM (p < 0.05). Fasting and postprandial inhibition of platelet aggregation with NO donors in T2DM was similar. T2DM patients had higher levels of oxidative stress in the fasting state and postprandially. There were no PP correlations with platelet NO resistance. In conclusion, there is platelet hyporesponsiveness to NO donors (SNP/GTN) in T2DM compared to controls, with increased ADP-induced platelet aggregation. Platelet abnormalities were associated with increased oxidative stress.
No takes yet. Share an insight, caveat, or question.
Anderson et al. (2005) conducted a case-control in Type 2 diabetes (n=27). Type 2 diabetes vs. Healthy controls was evaluated on Inhibition of ADP-induced platelet aggregation by sodium nitroprusside (SNP) (p=< 0.05). Type 2 diabetes was associated with platelet hyporesponsiveness to NO donors, with SNP inhibiting aggregation by 15.4% in diabetics versus 73.1% in healthy controls (p<0.05).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: